JAM1_HUMAN - dbPTM
JAM1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID JAM1_HUMAN
UniProt AC Q9Y624
Protein Name Junctional adhesion molecule A
Gene Name F11R
Organism Homo sapiens (Human).
Sequence Length 299
Subcellular Localization Cell junction, tight junction . Cell membrane
Single-pass type I membrane protein . Localized at tight junctions of both epithelial and endothelial cells.
Protein Description Seems to play a role in epithelial tight junction formation. Appears early in primordial forms of cell junctions and recruits PARD3. [PubMed: 11489913 The association of the PARD6-PARD3 complex may prevent the interaction of PARD3 with JAM1, thereby preventing tight junction assembly (By similarity Plays a role in regulating monocyte transmigration involved in integrity of epithelial barrier (By similarity Ligand for integrin alpha-L/beta-2 involved in memory T-cell and neutrophil transmigration]
Protein Sequence MGTKAQVERKLLCLFILAILLCSLALGSVTVHSSEPEVRIPENNPVKLSCAYSGFSSPRVEWKFDQGDTTRLVCYNNKITASYEDRVTFLPTGITFKSVTREDTGTYTCMVSEEGGNSYGEVKVKLIVLVPPSKPTVNIPSSATIGNRAVLTCSEQDGSPPSEYTWFKDGIVMPTNPKSTRAFSNSSYVLNPTTGELVFDPLSASDTGEYSCEARNGYGTPMTSNAVRMEAVERNVGVIVAAVLVTLILLGILVFGIWFAYSRGHFDRTKKGTSSKKVIYSQPSARSEGEFKQTSSFLV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
34PhosphorylationGSVTVHSSEPEVRIP
CCCEECCCCCCEECC
42.147646439
52PhosphorylationPVKLSCAYSGFSSPR
CEEEEEECCCCCCCC
17.4128152594
53PhosphorylationVKLSCAYSGFSSPRV
EEEEEECCCCCCCCE
18.1628152594
56PhosphorylationSCAYSGFSSPRVEWK
EEECCCCCCCCEEEE
42.8528152594
57PhosphorylationCAYSGFSSPRVEWKF
EECCCCCCCCEEEEE
17.9228152594
70PhosphorylationKFDQGDTTRLVCYNN
EECCCCCEEEEEECC
27.097646439
86MethylationITASYEDRVTFLPTG
ECCCHHHCEEEECCC
19.89115480717
88PhosphorylationASYEDRVTFLPTGIT
CCHHHCEEEECCCEE
21.9820068231
92PhosphorylationDRVTFLPTGITFKSV
HCEEEECCCEEEEEE
43.2820068231
95PhosphorylationTFLPTGITFKSVTRE
EEECCCEEEEEEECC
26.7620068231
97UbiquitinationLPTGITFKSVTREDT
ECCCEEEEEEECCCC
35.0521890473
98PhosphorylationPTGITFKSVTREDTG
CCCEEEEEEECCCCC
25.24-
100PhosphorylationGITFKSVTREDTGTY
CEEEEEEECCCCCEE
35.12-
104PhosphorylationKSVTREDTGTYTCMV
EEEECCCCCEEEEEE
27.0320068231
107PhosphorylationTREDTGTYTCMVSEE
ECCCCCEEEEEEECC
10.1722817900
110SulfoxidationDTGTYTCMVSEEGGN
CCCEEEEEEECCCCC
2.6128465586
133PhosphorylationLIVLVPPSKPTVNIP
EEEEECCCCCCCCCC
45.2420068231
136PhosphorylationLVPPSKPTVNIPSSA
EECCCCCCCCCCCCC
29.8920068231
141PhosphorylationKPTVNIPSSATIGNR
CCCCCCCCCCEECCE
28.8920068231
142PhosphorylationPTVNIPSSATIGNRA
CCCCCCCCCEECCEE
24.8720068231
144PhosphorylationVNIPSSATIGNRAVL
CCCCCCCEECCEEEE
31.2220068231
159PhosphorylationTCSEQDGSPPSEYTW
EEECCCCCCCCCCEE
41.7628348404
175O-linked_GlycosylationKDGIVMPTNPKSTRA
ECCEECCCCCCCCCC
46.1655824299
178UbiquitinationIVMPTNPKSTRAFSN
EECCCCCCCCCCCCC
67.5421890473
185N-linked_GlycosylationKSTRAFSNSSYVLNP
CCCCCCCCCCEEECC
28.6419159218
191N-linked_GlycosylationSNSSYVLNPTTGELV
CCCCEEECCCCCCEE
23.1019159218
224PhosphorylationGYGTPMTSNAVRMEA
CCCCCCCCCCHHHHH
19.2830576142
228UbiquitinationPMTSNAVRMEAVERN
CCCCCCHHHHHHHHH
18.1421890473
273PhosphorylationFDRTKKGTSSKKVIY
CCCCCCCCCCCEEEE
38.4118669648
274PhosphorylationDRTKKGTSSKKVIYS
CCCCCCCCCCEEEEC
49.1524719451
275PhosphorylationRTKKGTSSKKVIYSQ
CCCCCCCCCEEEECC
36.0118669648
277UbiquitinationKKGTSSKKVIYSQPS
CCCCCCCEEEECCCC
35.4921890473
280PhosphorylationTSSKKVIYSQPSARS
CCCCEEEECCCCCCC
12.3023927012
281PhosphorylationSSKKVIYSQPSARSE
CCCEEEECCCCCCCC
25.2121945579
284PhosphorylationKVIYSQPSARSEGEF
EEEECCCCCCCCCCC
28.7719664994
287PhosphorylationYSQPSARSEGEFKQT
ECCCCCCCCCCCCCC
50.0623927012
292UbiquitinationARSEGEFKQTSSFLV
CCCCCCCCCCCCCCC
48.6521890473
294PhosphorylationSEGEFKQTSSFLV--
CCCCCCCCCCCCC--
27.2528152594
295PhosphorylationEGEFKQTSSFLV---
CCCCCCCCCCCC---
19.3223401153
296PhosphorylationGEFKQTSSFLV----
CCCCCCCCCCC----
26.4523927012

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
284SPhosphorylationKinasePRKCAP17252
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of JAM1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of JAM1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ZO1_HUMANTJP1physical
10856295
PARD3_MOUSEPard3physical
11447115
CSKP_HUMANCASKphysical
11120739
AFAD_HUMANMLLT4physical
10856295
CSKP_HUMANCASKphysical
10856295
PEX19_HUMANPEX19physical
21988832
SGTA_HUMANSGTAphysical
21516116

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of JAM1_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-185 AND ASN-191, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-284; SER-287 ANDSER-296, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-273; SER-275; TYR-280;SER-281; SER-284 AND SER-287, AND MASS SPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-284, AND MASSSPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-280, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-280, AND MASSSPECTROMETRY.

TOP